Mind CBD Fleurs CBD 2 Grammes OG Kush (Outdoor) - CBD 12,9%
CBD OG Kush flower bag
Certificate of analysis CBD OG Kush flower

OG Kush (Outdoor) - CBD 12.9%

Grown in open fields in France, OG Kush delivers fresh, highly aromatic flowers with earthy, citrus and pine notes. A Sativa-dominant hybrid with 12.9% CBD and a bold character.
Regular price 10,80 € Sale price instead of 18,00 €

Availability: In stock – Ships within 24h

5,40 €/g
Tax included. Shipping calculated at checkout.
En Stock !
Livré en France sous 2 à 3 jours
Vous n'êtes pas en France ?

Summary

Great-value OG Kush CBD flower

  • Grown in fields in France (Outdoor)
  • Fresh and highly fragrant flowers
  • Sativa-dominant hybrid
  • Flavours: Earthy, Citrus, Pine
  • CBD 12.9%

See all products:

Details

Great-value OG Kush CBD flower

Grown in France in the fields of Beaujolais.

New arrival! Fresh and highly fragrant flowers!

Cultivation method
Grown outdoors in fields. Hand-harvested.

Species
Sativa-dominant hybrid.

Concentration
CBD: 12.88%
THC: 0.20%

Certification
Product grown in France, then certified by an independent, GMP-approved European laboratory. You will find the certificate of analysis for this product among the photos displayed on this page.

Legislation
100% legal product in the European Union. This hybrid is one of the varieties authorised in the European catalogue.

*Photos are non-contractual, taken by us and from the harvests currently on sale*

Flavours

Great-value OG Kush CBD flower

  • Earthy
  • Citrus
  • Pine

Profile

  • Sativa-dominant hybrid
  • Outdoor cultivation, Beaujolais
  • Hand-harvested

Similar products

Discover other Outdoor CBD flowers:

Sources and references (4)

Official and scientific sources on the regulation, safety, composition and quality of this type of product. They are provided for information and are not health claims.

  1. MILDECA (2021). L'indispensable sur... le cannabidiol (CBD). MILDECA — drogues.gouv.fr. View the source
  2. MILDECA (2023). Le CBD. drogues.gouv.fr (Mission interministérielle de lutte contre les drogues et les conduites addictives). View the source
  3. Chevallier C, Charuel L, Richeval C, Chaouachi L, Del Valle L, Eiden C, Gaulier JM, Batisse A (CEIP-A Paris, Lyon, Montpellier ; CHU Lille) (2023). Cannabidiol : analyse de produits « CBD non pharmaceutiques » disponibles sur le marché en France. MILDECA — drogues.gouv.fr (rapport CEIP-A financé par la MILDECA). View the source
  4. Dryburgh LM, Bolan NS, Grof CPL, et al. (2018). Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects. British Journal of Clinical Pharmacology. View the source

Recently viewed